Showing results (1041-1050 of 1,162) with videos related to
Sort By:
Pageof 117
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2016
TREC to WHERE? Transdisciplinary Research on Energetics and CancerKathryn H Schmitz, Sarah Gehlert, Ruth E Patterson, et al.Journal of Medicinal Chemistry|January 25, 2002
Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemiaKrzysztof W Pankiewicz, Krystyna B Lesiak-Watanabe, Kyoichi A Watanabe, et al.Cancer Causes & Control : CCC|December 25, 2010
Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL StudyLisa A Cadmus Bertram, Marcia L Stefanick, Nazmus Saquib, et al.Plos One|October 3, 2015
Determinants of Bed Net Use in Southeast Nigeria following Mass Distribution of LLINs: Implications for Social Behavior Change InterventionsCheryl L Russell, Adamu Sallau, Emmanuel Emukah, et al.The Pediatric Infectious Disease Journal|December 12, 2001
Risk factors for Candida species colonization of neonatal intensive care unit patientsL Saiman, E Ludington, J D Dawson, et al.International Health|August 16, 2014
'A living death': a qualitative assessment of quality of life among women with trichiasis in rural NigerStephanie L Palmer, Kate Winskell, Amy E Patterson, et al.Bioorganic & Medicinal Chemistry|April 28, 2016
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductaseJonathan M O Rawson, Megan E Roth, Jiashu Xie, et al.The Journal of Nutrition|May 17, 2006
Development of a glycemic index database for food frequency questionnaires used in epidemiologic studiesMarian L Neuhouser, Lesley F Tinker, Cynthia Thomson, et al.Clinical Pharmacology and Therapeutics|January 8, 2005
Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivoBarbara J Ring, Beverley E Patterson, Malcolm I Mitchell, et al.American Journal of Physiology. Renal Physiology|November 9, 2007
Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestationsJesus H Dominguez, Jawahar L Mehta, Dayuan Li, et al.Pageof 117